This message contains images. If you don't see images, click here to view.
Advertise in this news brief.

Text Version    RSS    Subscribe    Unsubscribe    Archive    Media Kit           May 21, 2014

Home     About SGO    Education    Membership    Clinical Practice    Public Policy    Blog    Partnerships    Store


Cervical cancer screening: Docs unconvinced on HPV DNA test
Medscape (free login required)
The US Food and Drug Administration recently approved the use of a human papillomavirus test as a primary cervical cancer screening test in women as young as 25 years, yet physicians are unlikely to ditch the Papanicolaou (Pap) test soon, experts say. Roche's cobas test is one of four HPV tests on the market, but thus far it is the only one approved for primary screening, rather than for use in conjunction with Pap tests.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Surgery isn't only option for women with ovarian cancer genes
HealthDay News via The Philadelphia Inquirer
Breast-feeding, birth control pills and having fallopian tubes tied may help reduce ovarian cancer risk in women with BRCA gene mutations, a new review suggests. Women with BRCA gene mutations are at increased risk for breast and ovarian cancers. These findings suggest ways that women with these inherited mutations can reduce their ovarian cancer risk without having their ovaries surgically removed, the University of Pennsylvania researchers said.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


HPV vaccination bill advances, despite opposition
The Associated Press via San Francisco Chronicle
Legislation seeking to encourage HPV vaccinations of South Carolina children advanced in the state Senate. However, supporters of the effort to educate parents on the cancer risks posed by the human papillomavirus worry that the stigma surrounding the sexually transmitted disease and opposition by the governor and socially conservative legislators will kill the bill's chances to save lives.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

  ChemoFx Improves Ovarian Cancer Outcomes
ChemoFx® provides invaluable information to physicians choosing from 20+ equivalent treatment recommendations without prior knowledge of how individual patients may respond. ChemoFx determines platinum resistance in primary ovarian cancer and demonstrates longer overall survival by 14 months in recurrent ovarian cancer, making it instrumental in improving patient outcomes.


Obesity may affect cancer patients' outcomes
Scientists know obese people have an increased risk of getting several types of cancer. But a new study suggests being obese also increases the chance that some patients' cancers will come back, and increases the likelihood that those patients will die from cancer. The study was released in advance of the 2014 American Society of Clinical Oncology annual meeting, which begins on May 30.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Proof that cancer stem cells exist?
Medical News Today
There has been much controversy over the compelling idea of cancer stem cells — a small subset of "master cells" that drives the growth and development of a patient's cancer. Now an international team of scientists that tracked the gene mutations driving cancer in patients with a rare blood condition that frequently develops into acute myeloid leukemia, says it has proved conclusively that cancer stem cells exist.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Exceptional Care, Close to Home

21st Century Oncology – the nation’s largest cancer treatment network and global leader in cancer care – providing integrated clinical teams treating patients collaboratively to improve outcomes.
Lantheus Proven Success
Discovering, developing and marketing innovative medical imaging agents provides a strong platform from which to bring forward new breakthrough tools for the diagnosis and management of disease. MORE

Cancer's potential on-off switch linked to epigenetics
Science Daily
A team of Boston University School of Medicine (BUSM) researchers have proposed that an "on and off" epigenetic switch could be a common mechanism behind the development of different types of cancer. Epigenetics is the phenomena whereby genetically identical cells express their genes differently, resulting in different physical traits.Researchers from the Boston University Cancer Center recently published two articles about this in Anticancer Research and Epigenomics.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Maintenance of Certification: Petition to recall ABIM's MOC requirements hits 15,000 signatures; recertification pass rates drop below 80 percent for internal medicine
Policy and Medicine
The rally against Maintenance of Certification (MOC) continues as more and more doctors have signed a petition to recall the American Board of Internal Medicine's (ABIM) new changes to its MOC requirements. ABIM now requires MOC activities be performed every two years and for every two years thereafter. The petition, which opened on March 10, 2014, has more than 15,000 signatures.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Breast cancer risk among childhood cancer survivors treated with radiation higher than previously thought
Journal of Clinical Oncology via Healio
Females who underwent chest irradiation during treatment for childhood cancer are at the same risk for breast cancer later in life than women with BRCA mutations, according to study results. Also, breast cancer-associated mortality among females treated for childhood cancer is substantial, results showed. The findings suggest breast cancer surveillance at a young age should be considered for these individuals, researchers wrote.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Women's Cancer News
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Jessica Taylor, Senior Medical Editor, 202-684-7169  
Contribute news

Inclusion of advertisements does not constitute SGO endorsement of company products or services.

Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.

This edition of the Women's Cancer News was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!

Recent issues

May 14, 2014
May 7, 2014
April 30, 2014

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063